Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4)NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE)…
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose…
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company…
Toronto, Ontario--(Newsfile Corp. - January 17, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or…
UTILITY has received a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024FDA granted Qualified Infectious…
MESQUITE, NV / ACCESSWIRE / January 17, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated…
PALO ALTO, CA / ACCESSWIRE / January 17, 2024 / Bioz, Inc., a leading Silicon Valley-based AI software company committed…
GENEVA, SWITZERLAND / ACCESSWIRE / January 17, 2024 / With cancer projected to escalate to 29 million cases by 2040[1],…
Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Market opportunity estimated to be greater than US$1…
STOCKHOLM, SWEDEN / ACCESSWIRE / January 16, 2024 / Promore Pharma (STO:PROMO) (FRA:8T0) Following the reverse acquisition of Promore Pharma…